Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS and Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
DALLAS - Starlight Therapeutics a Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective...